Inhoudsopgave:
|
\u003cp\u003eCovering all aspects of neuropathology, this updated volume in the \u003ci\u003eDiagnostic\u003c/i\u003e \u003ci\u003ePathology\u003c/i\u003e series is an \u003cb\u003eexcellent point-of-care resource for pathologists at all levels of experience and training\u003c/b\u003eâboth as a quick reference and as an efficient review to improve knowledge and skills. The third edition is an easy-to-use, one-stop reference for the \u003cb\u003emost recent clinical, pathological, histological, and molecular knowledge in the field\u003c/b\u003e. It offers complete information on lesions of the brain, sellar region, and peripheral nerves, as well as benign cysts and selected infectious, inflammatory, reactive, vascular, and cortical dysplastic lesions, enabling you to arrive at the correct diagnosis and prepare actionable, useful reports.\u003c/p\u003e\u003cul\u003e \u003cli\u003e \u003cp\u003eIncorporates new \u003cb\u003eWHO Classification of Tumors of the Central Nervous System, 5th Edition\u003c/p\u003e\u003c/b\u003e\u003c/li\u003e \u003cp\u003e \u003cli\u003e \u003cp\u003eOffers information on neoplasms of the brain, sellar region, and peripheral nerves, as well as benign cysts and selected infectious, inflammatory, reactive, and vascular lesions, \u003cb\u003eaiding you in arriving at the correct diagnosis\u003c/p\u003e\u003c/b\u003e\u003c/li\u003e \u003cp\u003e \u003cli\u003e \u003cp\u003eEmphasizes\u003cb\u003e surgical pathology \u003c/b\u003ebut also provides significant content on \u003cb\u003enonneoplastic diseases\u003c/b\u003e that present with focal lesions, especially those that are potentially misinterpreted as neoplasms\u003c/p\u003e\u003c/li\u003e \u003cp\u003e \u003cli\u003eContains a detailed \u003cb\u003emolecular diagnostics\u003c/b\u003e chapter with a section on methylation profiling, which has become indispensable as a method of tumor classification\u003c/li\u003e \u003cp\u003e \u003cli\u003e \u003cp\u003eFeatures \u003cb\u003enew and updated chapters\u003c/b\u003e detailing several types of tumors that have been reclassified due to recent molecular driver information, cIMPACT-NOW recommendations, and the \u003cb\u003eWHO Classification, 5th Edition \u003c/b\u003e\u003c/p\u003e\u003c/li\u003e\u003c/ul\u003e |
nl
en
